The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques
Abstract
INTRODUCTION: Ocular gene therapy represents fertile ground for rapid innovation, with ever-expanding therapeutic strategies, molecular targets, and indications. AREAS COVERED: Potential indications for ocular gene therapy have classically focused on inherited retinal disease (IRD) but more recently include acquired retinal diseases, such as neovascular age-related macular degeneration, geographic atrophy, and diabetic retinopathy. Ocular gene therapy strategies have proliferated recently, and include gene augmentation, gene inactivation, gene editing, RNA modulation, and gene-independent gene augmentation. Viral vector therapeutic constructs include adeno-associated virus and lentivirus and continue to evolve through directed evolution and rationale design. Ocular gene therapy administration techniques have expanded beyond pars plana vitrectomy with subretinal injection to intravitreal injection and suprachoroidal injection. EXPERT OPINION: The success of treatment for IRD, paired with the promise of clinical research in acquired retinal diseases and in administration techniques, has raised the possibility of in-office gene therapy for common retinal disorders within the next 5 to 10 years.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to its relative immune privilege, the eye represents an ideal environment to deliver viral vector-based in vivo gene therapy via intravitreal, subretinal, or suprachoroidal delivery.2,3”
In the citing paper
“In the United States, the era of gene therapy began in 2017 following Food and Drug Administration (FDA) approvals of ex-vivo gene therapy with chimeric antigen receptor (CAR)-T cells to treat B cell malignancies and adeno-associated virus (AAV) based in-vivo gene therapy to treat congenital blindness, specifically RPE65-associated Leber congenital amaurosis.1,2”
In the citing paper
“Gene therapy for retinal disease is especially promising since most inherited retinal disorders (IRDs) are monogenetic, cells are post-mitotic, and the imaging modalities used for diagnosis and monitoring are well-described and non-invasive.2,3”
In the citing paper
“VEGF is a key mediator of the pathological angiogenesis and the formation of macular choroidal neovascularisation (CNV) that, without intervention, is directly responsible for vision loss in nAMD.2,4,5,7”
In the citing paper
“Gene therapy, successfully used in rare, monogenetic disorders, may prove to be a durable management approach for common, polygenetic conditions, including neovascular age-related macular degeneration (nAMD).”
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C.-Y., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,331
Flaxman, S. R., Bourne, R. R. A., Resnikoff, S., Ackland, P., Braithwaite, T., Cicinelli, M. V., Das, A., Jonas, J. B., Keeffe, J., Kempen, J. H., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30393-5 · Cited by 3,477
Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31868-8 · Cited by 1,952
Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9873-9880.1998 · Cited by 1,815
Reprogramming to recover youthful epigenetic information and restore vision
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2975-4 · Cited by 820 · cited 1×
“This leads to a reversal of age-related DNA methylation and regeneration of retinal ganglion cell axons, showing reversal of vision loss in mouse studies to date [56].”
BackgroundDevelopment of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
Maeder, M. L., Stefanidakis, M., Wilson, C. J., Baral, R., Barrera, L. A., Bounoutas, G. S., Bumcrot, D., Chao, H., Ciulla, D. M., DaSilva, J. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0327-9 · Cited by 707
Partial recovery of visual function in a blind patient after optogenetic therapy
Sahel, J.-A., Boulanger-Scemama, E., Pagot, C., Arleo, A., Galluppi, F., Martel, J. N., Esposti, S. D., Delaux, A., de Saint Aubert, J.-B., de Montleau, C., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01351-4 · Cited by 700
Liew, G., Michaelides, M., & Bunce, C. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004015 · Cited by 663
Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa
Punzo, C., Kornacker, K., & Cepko, C. L. (2009) · Nature Neuroscience · doi:10.1038/nn.2234 · Cited by 514
Systematic Determination of the Packaging Limit of Lentiviral Vectors
Kumar, M., Keller, B., Makalou, N., & Sutton, R. E. (2001) · Human Gene Therapy · doi:10.1089/104303401753153947 · Cited by 454
Research works printed but not linked: 10
- Pennesi ME, 2022, Ophthalmol Retina, 2468
- Ho A, 2021, Presented at the Retina Society Meeting; September 20-October 2
- Ho AC, 2021, Presented at the Angiogenesis, Exudation, and Degeneration 2021 Conference
- Campochiaro PA, 2021, Presented at the Angiogenesis, Exudation, and Degeneration 2021 Conference
- Waheed N, 2022, Presented at: Angiogenesis, Exudation, and Degeneration
- Waheed N, Presented at the Angiogenesis, Exudation, and Degeneration 2021 Conference
- Li Q, 2008, Mol Vis, 14, 1760
- Pieramici D, 2021, Presented at: Annual Meeting of the American Society of Retina Specialists (ASRS)
- Emi K, 1989, Invest Ophthalmol Vis Sci, 30, 233
- London NJS, 2021, Presented at: Annual Meeting of the Retina Society. September 29-October 2
Cited by
Khanani, A. M., Boyer, D. S., Wykoff, C. C., Regillo, C. D., Busbee, B. G., Pieramici, D., Danzig, C. J., Joondeph, B. C., Major, J. C., Turpcu, A., et al. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2023.102394 · Cited by 76
“2,4,5,7 Repeated intravitreal bolus injections of VEGF inhibitors (anti-VEGF) can inhibit CNV growth and leakage and stabilise or improve vision outcomes in patients with nAMD.”
BackgroundSelf-citationInvernizzi, A., Chhablani, J. K., Viola, F., Gabrielle, P., Zarranz‐Ventura, J., & Staurenghi, G. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106670 · Cited by 32
Chen, K.-S., Chan, H.-C., & Chan, C.-M. (2025) · Drugs · doi:10.1007/s40265-025-02237-2 · Cited by 27
Progress and prospects of gene therapy in ophthalmology from 2000 to 2022: A bibliometric analysis
Li, B., Tan, W., Wang, Z., Zhou, H., Zou, J., Li, Y., Yoshida, S., & Zhou, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18228 · Cited by 14
Kulbay, M., Tuli, N., Akdag, A., Ali, S. K., & Qian, C. X. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144224 · Cited by 13
Metadata
- Authors
- Kovacs, K. D., Ciulla, T. A., & Kiss, S.
- Affiliations
- Weill Cornell Medicine (US)
- Indiana University School of Medicine (US)
- Corresponding author
- Kiss, Szilárd
- Venue
- Expert Opinion on Biological Therapy
- Publisher
- Informa UK Limited
- Published
- 2022-09-02
- Volume
- 22
- Issue
- 9
- Pages
- 1193-1208
- ISSN
- 1471-2598 (ISSN-L)
- 1744-7682
- OpenAlex
- W4294539283
- Cited by
- 20
- References
- 88
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 2 · 2023: 7
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Biological Therapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- ocular gene therapy, gene therapy vectors, adeno-associated virus, lentivirus, viral vector design, subretinal injection, intravitreal injection, suprachoroidal injection, inherited retinal disease, neovascular age-related macular degeneration, geographic atrophy, diabetic retinopathy, gene augmentation, gene inactivation, genome editing
- MeSH terms
- Dependovirus, Genetic Vectors, Humans, Retinal Diseases, Genetic Therapy, Gene Transfer Techniques, Intravitreal Injections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques. https://app.cochat.ai/papers/10.1080/14712598.2022.2121646
- The paper
- Kovacs, K. D., Ciulla, T. A., & Kiss, S. (2022). Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2022.2121646
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.